Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: A FONICAP randomised phase II study

A. Ardizzoni, G. F. Addamo, E. Baldini, U. Borghini, L. Portalone, F. De Marinis, R. Lionetto, P. F. Conte, P. Bruzzi, M. C. Pennucci, M. Venturini, M. Rinaldi, R. Rosso, F. Salvati

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: A FONICAP randomised phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences